Results 181 to 190 of about 23,814 (284)

Reproxalap ‐ A Novel Treatment Option for Allergic Conjunctivitis – A Comprehensive Narrative Review

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Allergic conjunctivitis is a prevalent, immune‐mediated hypersensitivity disorder of the ocular surface affecting 10%–20% of the global population. Current therapeutic options, while effective to some extent, are often limited by side effects and inconsistent efficacy.
Sanila Mughal, Roshanay Ejaz Awan, Hur Abbas, Zahra Sania, Ashna Habib, Syeda Kaneez Sakina, Amina Mahmud, Mohammed Mahmmoud Fadelallah Eljack   +7 more
wiley   +1 more source

Microplastics exposures in cataract surgery and potential clinical concerns. [PDF]

Sci Rep
Choi YH, Song MS, Park N, Park SA, Jung J, Choi YH, Kim DH.   +6 more
europepmc   +1 more source

Feasibility of In Vivo Retinal Flavoprotein Autofluorescence Imaging in a Magnetic‐Bead‐Induced Rodent Glaucoma Model

Journal of Biophotonics, Volume 19, Issue 6, June 2026.
A scanning laser ophthalmoscope, integrated with a real‐time optical coherence tomography (OCT) alignment monitor, detected flavoprotein fluorescence (FPF) signals associated with mitochondrial dysfunction in a rodent glaucoma model. Under 450‐nm excitation, experimental eyes showed spatially inhomogeneous signals that were absent under 505‐nm ...
Eun Ji Lee, Jiwon Kang, Jung‐Ho Chung, Kyoung Min Lee, Yu Jin Roh, Dong Kyun Han   +5 more
wiley   +1 more source

Patient-Reported Outcomes After Bilateral Implantation of Monofocal versus Monofocal-Plus Toric Intraocular Lenses. [PDF]

Clin Ophthalmol
Greenwood M, Wolsky J, Jemiyo C.
europepmc   +1 more source

Advances and Challenges in Sulcus-Implanted Intraocular Lenses: A Comprehensive Narrative Review. [PDF]

Ophthalmol Ther
Romano MR, Savastano A, Keegan D, Toro MD, Vidal-Aroca F, Di Simplicio S, Stanzel B, Fasolino G, Cabrera F, Rizzo S.   +9 more
europepmc   +1 more source

Innovative Drug Delivery Systems for the Treatment of Glaucoma

MedComm – Biomaterials and Applications, Volume 5, Issue 2, June 2026.
This review aims to provide a comprehensive overview of current topical drug delivery strategies for ocular hypotensive agents in glaucoma therapy. Additionally, it discusses the potential impact of emerging nanotechnological and biomaterial‐based systems in shaping the future of ophthalmic drug delivery, with an emphasis on enhancing efficacy, safety,
Jing Chu, Junzhi Li, Zhenlin Chen, Jinyu Zhang, Siqi Feng, Jiaying Huang, Yawen Chu, Xue Zhou, Wei Wang, Shangsi Chen   +9 more
wiley   +1 more source

Analysis of visual quality after implantation of diffractive multifocal intraocular lens Diff - aA in cataract patients. [PDF]

BMC Ophthalmol
Jingwen Z, Louxun S, Yifan Y, Shanshan D, Jingzhi S, Fengyan Z.   +5 more
europepmc   +1 more source

Smart Polymer‐Based Drug Delivery Systems for Managing Infective Conjunctivitis: Advances and Future Prospects

Nano Select, Volume 7, Issue 6, June 2026.
The introduction covers the background and significance of conjunctivitis. It continues with a review of etiology, epidemiology, and clinical manifestations. Diagnostic methods are described, followed by discussions on pathophysiology and classification. Current treatment strategies, preventive measures, and therapeutic challenges are analyzed.
Xia Linkang, Marwan Abdelmahmoud Abdelkarim Maki, Saad Tayyab, Sachin Thakur, Pankaj Kumar, Ritu Karwasra, Mahesh Harihar Behare, Nitin Sharma, Wan Hamirul Bahrin Wan Kamal, Oganeswary Kobi, Kushagra Khanna, Mogana Rajagopal   +11 more
wiley   +1 more source

Evaluation of visual outcomes, optical quality, and patient satisfaction with a novel monofocal intraocular lens. [PDF]

BMC Ophthalmol
Simsek C, Sul S, Kaderli A, Tamer Kaderli S, Simsek M, Karalezli A.   +5 more
europepmc   +1 more source

A randomized crossover clinical trial of the Deseyne contact lens for presbyopia with extended depth of focus

Optometry and Vision Science, Volume 103, Issue 6, June 2026.
ABSTRACT Purpose To evaluate the visual performance of a new daily wear presbyopia contact lens (Deseyne contact lens for presbyopia with extended depth of focus). Methods This was a randomized, crossover, and nondispensing clinical trial. Seventy‐eight presbyopic (45–70 years, mean = 53.9 years) habitual soft contact lens wearers were recruited with ...
Mark A. Bullimore, Charles B. Slonim, Stephen M. Montaquila, Eddie Catalfamo, Giancarlo Montani   +4 more
wiley   +1 more source